Skip to content

Paresthesia in novel technique continuous tumescent from groin-to-ankle level ablation and conventional tumescent from groin-to-knee level ablation)

Paresthesia in novel technique continuous tumescent from groin-to-ankle level ablation and conventional tumescent from groin-to-knee level ablation)

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240729002
Enrollment
44
Registered
2024-07-29
Start date
2024-05-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paresthesia in novel technique continuous tumescent from groin-to-ankle level ablation and conventional tumescent from groin-to-knee level ablation) in CVI patients Paresthesia, tumescent, groin-to-ankle level ablation, groin-to-knee level ablation, chronic venous insufficiency

Interventions

RFA at GSV with continous simultanously tumescent from groin-to-ankle ablation,RFA at GSV with conventional tumescent from groin-to-knee ablation with others intervention GSV below knee
groupA,groupB

Sponsors

Mahidol university, Ramathibodi hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1)CVI patient (C2s-C6) 2)Age more than 20 years old 3)Consent to research

Exclusion criteria

Exclusion criteria: 1)Coagulopathy 2)Previous venous intervention 3)ABI<0.6 4)Tumescent allergy -Can not follow up -Reject to research

Design outcomes

Primary

MeasureTime frame
Paresthesia 1day, 2weeks, 1month, 1year Paresthesia

Secondary

MeasureTime frame
pain, DVT, EHIT, CEAP, hyperpigmentation, VCSS score 1day, 2weeks, 1month, 1year pain, DVT, EHIT, CEAP, hyperpigmentation, VCSS score

Countries

Thailand

Contacts

Public ContactThatchaporn Bunsake

Faculty of medicine Ramathibodi hospital, Mahidol university

thatchaporn.b@gmail.com0855288951

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026